Home » Authors » Trista Morrison

Articles by Trista Morrison

Ambrilia Sells HIV Product To Merck For Up To $232M

Oct. 13, 2006

By Trista Morrison

Genentech Earnings: Lucentis Strong, Oncology Weakening

Oct. 12, 2006

By Trista Morrison

Genentech Inc. beat expectations for the third quarter and posted strong sales of Lucentis, but weaker-than-expected performance from its oncology franchise cast a shadow over the numbers. (BioWorld Today)

Genentech Earnings: Lucentis Strong, Oncology Weakening

Oct. 12, 2006

By Trista Morrison

Genentech Inc. beat expectations for the third quarter and posted strong sales of Lucentis, but weaker-than-expected performance from its oncology franchise cast a shadow over the numbers. (BioWorld Today)

EnVivo Raises $24M To Push CNS Programs Toward Clinic

Oct. 6, 2006

By Trista Morrison

EnVivo Raises $24M To Push CNS Programs Toward Clinic

Oct. 6, 2006

By Trista Morrison

HGS Updates Pipeline, Unveils Albuferon Phase III HCV Plans

Oct. 5, 2006

By Trista Morrison

HGS Updates Pipeline, Unveils Albuferon Phase III HCV Plans

Oct. 5, 2006

By Trista Morrison

Xanthus In-Licenses U.S. Rights To Oral Fludarabine

Oct. 4, 2006

By Trista Morrison

Xanthus In-Licenses U.S. Rights To Oral Fludarabine

Oct. 4, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...